Objective. Given a series of clinical scenarios, the student will follow a structured protocol to titrate, wean, and discontinue supplemental oxygen therapy while monitoring for patient deterioration and documenting each decision step.
This lesson, its worked examples and its practice questions has not yet been verified by a licensed clinician in the field or by a certification or approval body. It is a study draft and may contain errors. Do not use it to make decisions about any patient or medication. Always follow your instructor, your supervising professional, and current official references and regulations.
VoTechWorks program approval and accreditation are still in progress. Credentials are issued only by the certifying bodies named in each program, after their own exams.
Supplemental oxygen is a drug. Like any drug, it must be given at the right dose, adjusted as the patient's condition changes, and stopped when it is no longer needed. This lesson walks through a structured approach to titrating, weaning, and discontinuing oxygen therapy safely.
Both hypoxemia and hyperoxia carry risks. Untreated hypoxemia causes tissue injury and organ failure. Excessive oxygen can worsen outcomes in patients recovering from certain conditions, including some patients with chronic obstructive pulmonary disease (COPD) who depend partly on a hypoxic drive, and in neonates where hyperoxia is linked to retinopathy. Current evidence supports targeting a specific SpO2 range rather than simply administering the highest tolerated flow. For most hospitalized adults, a commonly accepted target is SpO2 88–92% in patients at risk of hypercapnia (e.g., COPD exacerbation) and 94–98% for patients without that risk. Always follow the ordering provider's written order and your facility protocol.
Titration means adjusting the oxygen flow rate or device to keep the patient within the target SpO2 range.
Starting point: Confirm the ordered target range and current baseline. Assess the patient: level of consciousness, work of breathing, respiratory rate, heart rate, skin color, and SpO2.
Upward titration (increasing O2): If SpO2 falls below the lower limit of the target range, increase flow in small increments — typically 1–2 L/min on a nasal cannula — and reassess within a few minutes. If the patient deteriorates rapidly, escalate to a higher-acuity delivery device (simple mask, non-rebreather, high-flow nasal cannula) and notify the provider immediately.
Downward titration (weaning): If SpO2 is consistently at or above the upper limit of the target range, reduce flow in small steps. After each reduction, allow adequate time (at least 5–10 minutes at rest; longer with activity or sleep) before reassessing. Decreasing flow while the patient is asleep or during ambulation requires extra vigilance because SpO2 may drop with positional change or increased demand.
Many facilities use a nurse- or therapist-driven protocol so that weaning can begin without waiting for a new physician order each time. These protocols specify:
When reading any protocol, identify its decision points: the specific numeric thresholds that drive each action. A flowchart is a useful tool for visualizing these branch points.
1. Verify the patient is clinically stable: no increased work of breathing, no new complaints of dyspnea, heart rate within normal limits.
2. Reduce flow by the smallest practical increment for the device in use.
3. Reassess SpO2 and clinical signs after an appropriate interval.
4. If stable within target range, continue monitoring and prepare for the next reduction or for discontinuation.
5. If SpO2 drops below the lower target threshold, return to the previous flow setting and document.
6. If the patient cannot maintain SpO2 despite return to prior settings, escalate and notify the provider.
Oxygen therapy may be discontinued when the patient maintains SpO2 within the target range on room air at rest, with activity, and (for inpatients) during sleep if applicable. Key criteria often include:
For home oxygen patients, discontinuation requires a formal reassessment — usually at 60–90 days post-discharge — demonstrating that the patient no longer meets qualification criteria on room air at rest and with exertion. Discontinuation of home oxygen must be documented and communicated to the prescribing provider.
Every change must be recorded: date, time, flow rate before and after adjustment, device used, SpO2 and other vital signs, patient response, and your clinical reasoning. Accurate documentation protects the patient, supports continuity of care, and satisfies legal and licensing requirements. A therapy flow sheet is the standard tool in most acute care settings.
Answer each question, then check it. Nothing is recorded; this is your own practice.
A free tech program — complimentary, as our commitment to get America working. Help us build VoTechWorks. Tell us what works, what doesn’t, and what you want to learn.